SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment
Cells · 2024
DOI: 10.3390/cells13100796 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Ralf-Peter Czekay und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Cholangiocarcinoma, Cancer-Associated Fibroblasts, Disease Progression. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, Friedman Family Cancer Research Foundation, New York State Department of Health Empire State Stem Cell Trust.
Abstract (Originalsprache)
A heterogenous population of inflammatory elements, other immune and nonimmune cells and cancer-associated fibroblasts (CAFs) are evident in solid malignancies where they coexist with the growing tumor mass. In highly desmoplastic malignancies, CAFs are the prominent mesenchymal cell type in the tumor microenvironment (TME), where their presence and abundance signal a poor prognosis. CAFs play a major role in the progression of various cancers by remodeling the supporting stroma into a dense, fibrotic matrix while secreting factors that promote the maintenance of cancer stem-like characteristics, tumor cell survival, aggressive growth and metastasis and reduced sensitivity to chemotherapeutics. Tumors with high stromal fibrotic signatures are more likely to be associated with drug resistance and eventual relapse. Identifying the molecular underpinnings for such multidirectional crosstalk among the various normal and neoplastic cell types in the TME may provide new targets and novel opportunities for therapeutic intervention. This review highlights recent concepts regarding the complexity of CAF biology in cholangiocarcinoma, a highly desmoplastic cancer. The discussion focuses on CAF heterogeneity, functionality in drug resistance, contributions to a progressively fibrotic tumor stroma, the involved signaling pathways and the participating genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USA.
- Department of Pathology & Laboratory Medicine, Albany Medical College, Albany, NY 12208, USA.
ORCID-Profile: Hwajeong Lee
Förderung
- National Institutes of Health
- Friedman Family Cancer Research Foundation
- New York State Department of Health Empire State Stem Cell Trust
- Charlotte P. Graver Fund
- Edith Dickstein and Sylvan Kessler Estate Foundation
- Grace A. Miller Foundation for Pancreatic Cancer Research
Zitieren
APA
Czekay, R. P., Higgins, C. E., Aydin, H. B., Samarakoon, R., Subasi, N. B., Higgins, S. P., Lee, H., & Higgins, P. J. (2024). SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment. Cells. https://doi.org/10.3390/cells13100796
Vancouver
Czekay RP, Higgins CE, Aydin HB, Samarakoon R, Subasi NB, Higgins SP, et al. SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment. Cells. 2024. doi:10.3390/cells13100796
BibTeX
@article{Czekay2024,
author = {Czekay, Ralf-Peter and Higgins, Craig E and Aydin, Hasan Basri and Samarakoon, Rohan and Subasi, Nusret Bekir and Higgins, Stephen P and Lee, Hwajeong and Higgins, Paul J},
title = {SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13100796}
}
EUVIMED